Verition Fund Management
RDHL

Verition Fund Management’s Redhill Biopharma RDHL Stock Holding History

Verition Fund Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14
Closed -$7K – 2618
2022
Q3 		$7K Hold
14
– – ﹤0.01% 2904
2022
Q2 		$12K Buy
+14
New +$19.2K ﹤0.01% 2247

Other funds holding RDHL

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Verition Fund Management's RDHL Position: Q4 2022 in Review

Verition Fund Management sold out of Redhill Biopharma (RDHL) in Q4 2022, closing a stake of 14 shares — an estimated $7K sold.

Verition Fund Management first reported a position in RDHL in Q2 2022 and held it in 2 quarters. The position peaked at $12K in Q2 2022. 37 funds tracked by Wall St. Rank hold RDHL as of Q4 2022.

  • Verition Fund Management reported no remaining Redhill Biopharma position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 14 Redhill Biopharma shares in Q4 2022, an estimated $7K.
  • Verition Fund Management first reported a position in Redhill Biopharma in Q2 2022 and held it in 2 quarters.
  • Verition Fund Management's Redhill Biopharma position peaked at $12K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.